Cadralazine

Jump to: navigation, search

{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 443953677 | IUPAC_name = ethoxy-N'-{6-[ethyl(2-hydroxypropyl)amino]pyridazin-3-yl}carbohydrazide | image = Cadralazine Wiki Str.png

| alt2 = Cadralazine molecule

| tradename = | Drugs.com = International Drug Names | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration =

| bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion =

| CAS_number_Ref =  ☑Y | CAS_number = 64241-34-5 | ATC_prefix = C02 | ATC_suffix = DB04 | PubChem = 2515 | ChEMBL_Ref =  ☒N | ChEMBL = 2106561 | DrugBank_Ref =  ☑Y | DrugBank = | UNII_Ref =  ☑Y | UNII = 8T96I3U713 | ChemSpiderID_Ref =  ☒N | ChemSpiderID = 2420 | smiles = O=C(OCC)NNc1nnc(N(CC(O)C)CC)cc1 | InChI = 1/C12H21N5O3/c1-4-17(8-9(3)18)11-7-6-10(13-15-11)14-16-12(19)20-5-2/h6-7,9,18H,4-5,8H2,1-3H3,(H,13,14)(H,16,19) | InChIKey = QLTVVOATEHFXLT-UHFFFAOYAD | StdInChI_Ref =  ☒N | StdInChI = 1S/C12H21N5O3/c1-4-17(8-9(3)18)11-7-6-10(13-15-11)14-16-12(19)20-5-2/h6-7,9,18H,4-5,8H2,1-3H3,(H,13,14)(H,16,19) | StdInChIKey_Ref =  ☒N | StdInChIKey = QLTVVOATEHFXLT-UHFFFAOYSA-N

| C=12 | H=21 | N=5 | O=3 | molecular_weight = 283.33 g/mol }}

WikiDoc Resources for Cadralazine

Articles

Most recent articles on Cadralazine

Most cited articles on Cadralazine

Review articles on Cadralazine

Articles on Cadralazine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cadralazine

Images of Cadralazine

Photos of Cadralazine

Podcasts & MP3s on Cadralazine

Videos on Cadralazine

Evidence Based Medicine

Cochrane Collaboration on Cadralazine

Bandolier on Cadralazine

TRIP on Cadralazine

Clinical Trials

Ongoing Trials on Cadralazine at Clinical Trials.gov

Trial results on Cadralazine

Clinical Trials on Cadralazine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cadralazine

NICE Guidance on Cadralazine

NHS PRODIGY Guidance

FDA on Cadralazine

CDC on Cadralazine

Books

Books on Cadralazine

News

Cadralazine in the news

Be alerted to news on Cadralazine

News trends on Cadralazine

Commentary

Blogs on Cadralazine

Definitions

Definitions of Cadralazine

Patient Resources / Community

Patient resources on Cadralazine

Discussion groups on Cadralazine

Patient Handouts on Cadralazine

Directions to Hospitals Treating Cadralazine

Risk calculators and risk factors for Cadralazine

Healthcare Provider Resources

Symptoms of Cadralazine

Causes & Risk Factors for Cadralazine

Diagnostic studies for Cadralazine

Treatment of Cadralazine

Continuing Medical Education (CME)

CME Programs on Cadralazine

International

Cadralazine en Espanol

Cadralazine en Francais

Business

Cadralazine in the Marketplace

Patents on Cadralazine

Experimental / Informatics

List of terms related to Cadralazine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Cadralazine is an antihypertensive of the hydrazinophthalazine chemical class.

References


Template:Nonsympatholytic vasodilatory antihypertensives Template:Hydrazines


Template:Antihypertensive-stub


Linked-in.jpg